These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36479105)

  • 21. Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment.
    Wu X; Ma W; Mei C; Chen X; Yao Y; Liu Y; Qin X; Yuan Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):97. PubMed ID: 32487115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy.
    Zhang X; Cheng C; Sun W; Wang H
    Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment.
    Liu B; Saber A; Haisma HJ
    Drug Discov Today; 2019 Apr; 24(4):955-970. PubMed ID: 30849442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR Cas System: An efficient tool for cancer modelling.
    Akhtar M; Jamal T; Khan M; Khan SR; Haider S; Jalil F
    J Pak Med Assoc; 2021 Feb; 71(2(B)):718-724. PubMed ID: 33941966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9 in cancer: An attempt to the present trends and future prospects.
    Kaligotla VSA; Jasti T; Kandra P
    Biotechnol Appl Biochem; 2022 Jun; 69(3):1238-1251. PubMed ID: 34033692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy.
    Guo N; Liu JB; Li W; Ma YS; Fu D
    J Adv Res; 2022 Sep; 40():135-152. PubMed ID: 36100322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.
    Zhang H; Qin C; An C; Zheng X; Wen S; Chen W; Liu X; Lv Z; Yang P; Xu W; Gao W; Wu Y
    Mol Cancer; 2021 Oct; 20(1):126. PubMed ID: 34598686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancements in CRISPR/Cas9 technology-Focusing on cancer therapeutics and beyond.
    Mirza Z; Karim S
    Semin Cell Dev Biol; 2019 Dec; 96():13-21. PubMed ID: 31150758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA fragment editing of genomes by CRISPR/Cas9.
    Li JH; Shou J; Wu Q
    Yi Chuan; 2015 Oct; 37(10):992-1002. PubMed ID: 26496751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy.
    Rasul MF; Hussen BM; Salihi A; Ismael BS; Jalal PJ; Zanichelli A; Jamali E; Baniahmad A; Ghafouri-Fard S; Basiri A; Taheri M
    Mol Cancer; 2022 Mar; 21(1):64. PubMed ID: 35241090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
    J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
    Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
    Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progresses of CRISPR/Cas9 genome editing in forage crops.
    Ul Haq SI; Zheng D; Feng N; Jiang X; Qiao F; He JS; Qiu QS
    J Plant Physiol; 2022 Dec; 279():153860. PubMed ID: 36371870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.